Nav1.8
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) | |||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 3: 38.7 – 38.82 Mb | Chr 9: 119.44 – 119.55 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
Nav1.8 is a
Nav1.8-containing channels are
The specific location of Nav1.8 in sensory neurons of the DRG may make it a key therapeutic target for the development of new analgesics[11] and the treatment of chronic pain.[12]
Function
Voltage-gated sodium ion channels (VGSC) are essential in producing and propagating
Although the early studies on the biophysics of NaV1.8 channels were carried out in rodent channels, more recent studies have examined the properties of human NaV1.8 channels. Notably, human NaV1.8 channels exhibit an inactivation voltage-dependence that is even more depolarized than that in rodents, and it also exhibits a larger persistent current.[20] Thus, the influence of human NaV1.8 channels on firing of sensory neurons may be even larger than that of rodent NaV1.8 channels.
Gain-of-function mutations of NaV1.8, identified in patients with painful peripheral neuropathies, have been found to make DRG neurons hyper excitable, and thus are causes of pain.[21][22] Although NaV1.8 is not normally expressed within the cerebellum, its expression is up-regulated in cerebellar Purkinje cells in animal models of MS (Multiple Sclerosis), and in human MS.[23] The presence of NaV1.8 channels within these cerebellar neurons, where it is not normally present, increases their excitability and alters their firing pattern in vitro,[24] and in rodents with experimental autoimmune encephalomyelitis, a model of MS.[25] At a behavioral level, the ectopic expression of NaV1.8 within cerebellar Purkinje neurons has been shown to impair motor performance in a transgenic model.[26]
Clinical significance
Pain signalling pathways
Nociceptors are different from other sensory neurons in that they have a low activating threshold and consequently increase their response to constant stimuli. Therefore, nociceptors are easily sensitised by agents such as bradykinin and nerve growth factor, which are released at the site of tissue injury, ultimately causing changes to ion channel conductance. VGSCs have been shown to increase in density after nerve injury.[27] Therefore, VGSCs can be modulated by many different hyperalgesic agents that are released after nerve injury. Further examples include prostaglandin E2 (PGE2), serotonin and adenosine, which all act to increase the current through Nav1.8.[28]
Prostaglandins such as PGE2 can sensitise nociceptors to thermal, chemical and mechanical stimuli and increase the excitability of DRG sensory neurons. This occurs because PGE2 modulates the trafficking of Nav1.8 by binding to G-protein-coupled EP2 receptor, which in turn activates protein kinase A.[29][30] Protein kinase A phosphorylates Nav1.8 at intracellular sites, resulting in increased sodium ion currents. Evidence for a link between PGE2 and hyperalgesia comes from an antisense deoxynucleotide knockdown of Nav1.8 in the DRG of rats.[31] Another modulator of Nav1.8 is the ε isoform of PKC. This isoform is activated by the inflammatory mediator bradykinin and phosphorylates Nav1.8, causing an increase in sodium current in the sensory neurons, which promotes mechanical hyperalgesia.[32]
Brugada syndrome
Mutations in SCN10A are associated with
Membrane trafficking
Nerve growth factor levels in inflamed or injured tissues are increased creating an increased sensitivity to pain (hyperalgesia).
In
Painful peripheral neuropathies
Painful
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000185313 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000034533 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Entrez Gene: sodium channel".
- S2CID 45480324.
- PMID 10198179.
- S2CID 7332624.
- ^ a b
Akopian AN, Souslova V, England S, Okuse K, Ogata N, Ure J, Smith A, Kerr BJ, McMahon SB, Boyce S, Hill R, Stanfa LC, Dickenson AH, Wood JN (June 1999). "The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways". Nature Neuroscience. 2 (6): 541–8. S2CID 17487906.
- ^
Akopian AN, Sivilotti L, Wood JN (January 1996). "A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons". Nature. 379 (6562): 257–62. S2CID 4360775.
- PMID 17766042.
- ^ a b
Swanwick RS, Pristerá A, Okuse K (December 2010). "The trafficking of Na(V)1.8". Neuroscience Letters. 486 (2): 78–83. PMID 20816723.
- ^
Strickland IT, Martindale JC, Woodhams PL, Reeve AJ, Chessell IP, McQueen DS (July 2008). "Changes in the expression of NaV1.7, NaV1.8 and NaV1.9 in a distinct population of dorsal root ganglia innervating the rat knee joint in a model of chronic inflammatory joint pain". European Journal of Pain. 12 (5): 564–72. S2CID 24952010.
- PMID 12451128.
- S2CID 11579149.
- S2CID 206054345.
- PMID 16478543.
- PMID 17483457.
- ^ S2CID 4391511.
- PMID 25787950.
- PMID 23986244.
- PMID 11027357.
- S2CID 34784900.
- S2CID 34656521.
- S2CID 25128887.
- ^
Devor M; Govrin-Lippmann R & Angelides (1993). "Na+ Channel lmmunolocalization in Peripheral Mammalian Axons and Changes following Nerve Injury and Neuroma Formation". PMID 7683047.
- ^
Gold MS, Reichling DB, Shuster MJ, Levine JD (February 1996). "Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors". Proceedings of the National Academy of Sciences of the United States of America. 93 (3): 1108–12. PMID 8577723.
- PMID 8887754.
- ^
Liu C, Li Q, Su Y, Bao L (March 2010). "Prostaglandin E2 promotes Na1.8 trafficking via its intracellular RRR motif through the protein kinase A pathway". Traffic. 11 (3): 405–17. S2CID 997800.
- ^
Khasar SG, Gold MS & Levine JD (1998). "A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat". S2CID 5614913.
- ^
Wu DF, Chandra D, McMahon T, Wang D, Dadgar J, Kharazia VN, Liang YJ, Waxman SG, Dib-Hajj SD, Messing RO (April 2012). "PKCε phosphorylation of the sodium channel NaV1.8 increases channel function and produces mechanical hyperalgesia in mice". The Journal of Clinical Investigation. 122 (4): 1306–15. PMID 22426212.
- PMID 24998131.
- PMID 31292628. Retrieved 27 April 2021.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - PMID 32121523.)
{{cite journal}}
: CS1 maint: multiple names: authors list (link - ^
McMahon SB (March 1996). "NGF as a mediator of inflammatory pain". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 351 (1338): 431–40. PMID 8730782.
- ^
Okuse K, Malik-Hall M, Baker MD, Poon WY, Kong H, Chao MV, Wood JN (June 2002). "Annexin II light chain regulates sensory neuron-specific sodium channel expression". Nature. 417 (6889): 653–6. S2CID 4423351.
- ^
Foulkes T, Nassar MA, Lane T, Matthews EA, Baker MD, Gerke V, Okuse K, Dickenson AH, Wood JN (October 2006). "Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior" (PDF). The Journal of Neuroscience. 26 (41): 10499–507. PMID 17035534.
- ^ a b
Pristerà A, Baker MD, Okuse K (2012). "Association between tetrodotoxin resistant channels and lipid rafts regulates sensory neuron excitability". PLOS ONE. 7 (8): e40079. PMID 22870192.
- ^
Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG (May 2012). "Small-fibre neuropathies--advances in diagnosis, pathophysiology and management". Nature Reviews. Neurology. 8 (7): 369–79. S2CID 8804151.
- ^
Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, Estacion M, Lauria G, Vanhoutte EK, Gerrits MM, Dib-Hajj S, Drenth JP, Waxman SG, Merkies IS (January 2012). "Gain of function Naν1.7 mutations in idiopathic small fiber neuropathy". Annals of Neurology. 71 (1): 26–39. S2CID 11711575.
Further reading
- Okuse K (2007). "Pain signalling pathways: from cytokines to ion channels". The International Journal of Biochemistry & Cell Biology. 39 (3): 490–6. PMID 17194618.
- Waxman SG (July 2013). "Painful Na-channelopathies: an expanding universe". Trends in Molecular Medicine. 19 (7): 406–9. PMID 23664154.
- Lai J, Porreca F, Hunter JC, Gold MS (2004). "Voltage-gated sodium channels and hyperalgesia". Annual Review of Pharmacology and Toxicology. 44: 371–97. PMID 14744251.
- Wood JN, Boorman JP, Okuse K, Baker MD (October 2004). "Voltage-gated sodium channels and pain pathways". Journal of Neurobiology. 61 (1): 55–71. PMID 15362153.
- Malik-Hall M, Poon WY, Baker MD, Wood JN, Okuse K (February 2003). "Sensory neuron proteins interact with the intracellular domains of sodium channel NaV1.8". Brain Research. Molecular Brain Research. 110 (2): 298–304. PMID 12591166.
- Yamaoka K, Inoue M, Miyazaki K, Hirama M, Kondo C, Kinoshita E, Miyoshi H, Seyama I (March 2009). "Synthetic ciguatoxins selectively activate Nav1.8-derived chimeric sodium channels expressed in HEK293 cells". The Journal of Biological Chemistry. 284 (12): 7597–605. PMID 19164297.
- Choi JS, Hudmon A, Waxman SG, Dib-Hajj SD (July 2006). "Calmodulin regulates current density and frequency-dependent inhibition of sodium channel Nav1.8 in DRG neurons". Journal of Neurophysiology. 96 (1): 97–108. PMID 16598065.
- Liu CJ, Priest BT, Bugianesi RM, Dulski PM, Felix JP, Dick IE, Brochu RM, Knaus HG, Middleton RE, Kaczorowski GJ, Slaughter RS, Garcia ML, Köhler MG (February 2006). "A high-capacity membrane potential FRET-based assay for NaV1.8 channels". Assay and Drug Development Technologies. 4 (1): 37–48. PMID 16506887.
- Browne LE, Blaney FE, Yusaf SP, Clare JJ, Wray D (April 2009). "Structural determinants of drugs acting on the Nav1.8 channel". The Journal of Biological Chemistry. 284 (16): 10523–36. PMID 19233853.
- Rabert DK, Koch BD, Ilnicka M, Obernolte RA, Naylor SL, Herman RC, Eglen RM, Hunter JC, Sangameswaran L (November 1998). "A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A". Pain. 78 (2): 107–14. S2CID 45480324.
- Plummer NW, Meisler MH (April 1999). "Evolution and diversity of mammalian sodium channel genes". Genomics. 57 (2): 323–31. PMID 10198179.
- Catterall WA, Goldin AL, Waxman SG (December 2005). "International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels". Pharmacological Reviews. 57 (4): 397–409. S2CID 7332624.